Can I read Quinoxaline Inhibitors of LRP5/6-Sclerostin on EtoBox?

Quinoxaline Inhibitors of LRP5/6-Sclerostin by 900chp is a document available to read on EtoBox.

What is Quinoxaline Inhibitors of LRP5/6-Sclerostin about?

This study identifies quinoxaline derivatives as novel inhibitors of the LRP5/6-sclerostin interaction, which is crucial for regulating the Wnt/b-catenin signaling pathway and has implications for osteoporosis treatment. Through pharmacophore-based virtual screening and docking simulations, the compound BMD4503 was optimized to enhance its binding affinity and disrupt sclerostin

Author

900chp

Language

EN